Care sunt etapele de finantare si dezvoltare pentru firme de tip startup?

startup sabinpiso.com

Toate companiile pornesc de la o idee … insa ca sa transformi aceasta idee intr-o afacere profitabila ai nevoie de finantare.  Avand fondurile necesare, vei putea lansa ideea pe piata si ulterior vei putea transforma ideea intr-o companie de succes.

Cu toate ca unele firme de tip startup sunt finantat cu fonduri personale sau cu imprumuturi personale la banca, majoritatea lucreaza cu “venture capitalists”, care ramane totusi cea mai utilizata varianta.  Finantarea obtinuta astfel, se obtine in schimbul cedarii de actiuni din firma.

Acest tip de finantare este de obicei facut in etapele care vor sunt descrise aici pe scurt :

 

PRE-SEED  (stadiu de idee)

Finantarea de tip pre-seed este primul pas in ridicarea de fonduri necesare pe baza de vanzare de actiuni.  In aceasta etapa, firma ta dezvolta conceptul sau prototipul cu doar cativa angajati sau parteneri (de obicei esti sunt doar cei care au avut ideea).  Acest stadiu de dezvoltare nu permite acordarea unui imprumut de catre banca, inca firma nu genereaza venituri si nu are garantii.  De asemenea, fondurile de tip venture capital, nu vor intra in societatea ta incat nu ai aratat ca produsul tau e vandabil si nu ai generat inca venituri pe baza carora acestia sa evalueze si sa investeasca.  Pe scurt, in aceasta etapa, riscul este foarte mare pentru orice investitor, incat foarte putine companii reusesc sa aiba un produs bun si vandabil.

In acest stadiu, ai nevoie de fonduri de tip pre-seed, care vin in general din economiile tale, de la parinti, rude, prieteni, sisteme crowdfunding (cum ar fi kickstarter), granturi in functie de domeniul de activitate, incubatoare sau anumiti investitori privati .

O runda de finantare normala in aceasta etapa, este de sub 10 000 euro dar acest capital este critic pentru dezvoltarea ideii in prototip / concept.  Aceste fonduri sunt de obicei folosite pentru ca ai nevoie sa iti faci un website, sa cumperi diverse materiale de care ai nevoie pentru produsul pe care vrei sa il vinzi, ca sa poti sa dovedesti ca exista cerere pe piata si sa poti sa testezi produsul.

Ca sa poti obtine aceasta finantare critica, este bine ca inainte sa discuti cu orice posibil investitor, sa ai un plan de afaceri viabil si o firma in care acesta sa poata investi.

 

SEED  (stadiu incipient / ideea se transforma in prototip)

In aceasta runda, de obicei firma (startup-ul) trece la etapa de finalizare a produsului si pozitionarea acestuia in piata.  Cand ajungi la aceasta etapa, te focusezi la calitatea si caracteristicile produsului tau finit si a pietei careia te adresezi.

Cu alte cuvinte, partea de seed aduce un suport sustinut afacerii tale prin pregatirea produsului final pentru intrarea pe piata.  (marketing, product engineering, design, packaging, etc)

Investitiile in aceasta etapa pot ajunge chiar si la 1 mil $.  In aceasta etapa te adresezi incubatoarelor, acceleratoarelor (care au intrat langa tine chiar de la stadiul pre-seed), investitorilor de tip “angel investor”, unui numar limitat de fonduri de VC (early stage) care intra chiar din stadiul de SEED.

 

EARLY-STAGE  (stadiu incipient de introducere pe piata a produsului)

Investitorii se asteapta sa gaseasca in aceasta etapa o companie care a vandut deja cateva produse, a dovedit ca ideea initiala poate produce venituri si exista o baza de clienti.  Aici puteti primi sume mari (de la cateva milioane pana la sute de milioane) pentru investitie de la mai multe variante de investitori, bani care se vor duce pe cresterea bazei de clienti, cresterea fortei de vanzari, identificarea zonelor de crestere si pe finantarea stocurilor sau resurselor pentru crestere accelerata.

 

A, B, C rounds (stadiu de dezvoltare afacere, accelerand pentru a ajunge la breakeven sau chiar profitabilitate)

Daca afacerea are nevoie de alte fonduri suplimentare pentru cresterea veniturilor si a cotei de piata, impreuna cu dezvoltarea resurselor umane ale companiei, se trece la aceste runde de finantare.  Cu cat compania e mai aproape de generare de profit sau macar de punctul de breakeven, cu atat runda ta de finantare va avea mai mult succes, afacerea este deja mult mai sigura cu sanse mari de reusita.

 

Final Stage

Acest stadiu de finantare va fi necesar doar pentru expansiunea masiva.  Astfel, vei avea nevoie de capital masiv de lucru pentru stoc, resurse umane pentru expansiune, cercetare si dezvoltare pentru produsele actuale si produse noi care sunt necesare pentru acapararea cotei de piata, etc.

In acest moment firma ta a dovedit tot ce trebuia dovedit si toata echipa se va concentra doar la expansiune si marirea profitului generat.

 

Cel mai mare jucător pe piața real estate rezidential din Transilvania vrea sa extinda la nivel national si cauta parteneri.

Maurer Imobiliare, cel mai mare jucător de pe piața de real estate rezidential din centrul țării anunță intenția de dezvoltare și extindere la nivel national. Rezultatele companiei susțin cu cifre această intenție a conducerii. Astfel, doar în 2015, Maurer Imobiliare a vândut peste 700 de apartamente până în luna septembrie, cu o margine EBITDA estimata pe 2015 de 34%, respectiv un minim de 9 mil. EUR, existand posibilitatea de a atinge un numar de 1000 de apartamente vândute până la finalul anului.

Dezghețarea pieței imobiliare s-a tradus pentru compania condusă de sasul Simon Maurer intr-o  creștere de 18% a numarului de apartamente vândute în 2015, față de anul precedent, iar potrivit estimărilor, 2016 va aduce un plus de 20% față de 2015.

Acest trend ascendent al evoluției vânzărilor este generat de increderea clienților în compania bazată pe valori germane, clienți care au cumpărat, în proporție de 98%, apartamente în stadiu de proiect și cu un an înainte de livrarea unităților locative.

Succesul pe care compania Maurer Imobiliare l-a înregistrat în orașele Brașov și Sibiu a generat un val record de cereri de implementare a proiectelor dezvoltate de firmă în mai multe orașe-cheie ale țării.

Simon Maurer, președintele companiei, consideră că a sosit momentul ca firma sa faca următorul pas spre extindere la nivel național. Astfel, în planul strategic al companiei sunt luate în considerare mai multe zone, pe care managementul companiei le urmărește de mai multă vreme.

În acest sens, Simon Maurer a mandatat exclusiv casa de investiții Capital Partners pentru identificarea unui partener strategic sau financiar care să propulseze Maurer Imobiliare la nivel national, având în vedere oportunitățile excelente de care se bucură în prezent.

Idee de startup! Cumperi un apartament si il dai spre inchiriere pe AirBNB.

AirBNB a ajuns sa genereze mai mult venit anual pentru proprietari decat inchirierea clasica pe termen lung.  Trebuie doar sa urmaresti cateva conditii pentru a avea o locatie buna.

Despre AirBNB (www.airbnb.com)

 

AIRBNB a pornit la drum in 2007 in San Francisco, cand Joe Gebbia si Brian Chesky se gandea cum sa faca sa isi plateasca chiria, incat nu isi permiteau.  Acestia au inceput sa dea in chirie 3 paturi in apartamentul lor, oferind si micul dejun.  Au construit un website simplu si au inceput sa inchirieze aceste paturi, reusind sa aiba 3 clienti.

In 2008, l-au adus in echipa si pe Nathan Blecharczyk, care era un tehnician destul de bun si care putea sa ii ajute cu partea tehnica pentru dezvoltarea ideii lor.  In acelasi an, au lansat o firma prin care vroiau sa beneficieze de avantajul generat de lipsa camerelor de hotel in zona.  In 2009 s-au imprietenit cu Paul Graham si au intrat impreuna in programul Y Combinator care i-a ajutat sa obtina 20 000 $ in fonduri.  In 2009 numele fostei firme (Airbed&Breakfast) este schimbat in AirBNB.  Din 2009 acestia primesc 600 000 $ de la Sequoia Capital si Y Ventures.  In 2010 primesc fonduri de 7.2 milioane $ pentru dezvoltarea companiei de la mai multi investitori.  In 2011, AirBNB mai primeste 112 milioane $ de la alti investitori, printre care si Ashton Kutcher, care intra si in advisory board.  In 2012, compania mai atrage 200 milioane $.  Dupa ce in primavara din 2014 AirBNB ajunge la 10 milioane de oaspeti si 550 000 proprietati listate pe glob, AirBNB mai atrage 500 milioane %, evaluand compania astfel la 10 miliarde $.

 

 

Despre viitorul agentiilor imobiliare si cum sa faci mai multi bani FARA acestea.

 Daca ai un apartament ok, intr-o zona centrala, atunci AirBNB face mult mai mult sens pentru tine decat un inchiriat pe termen lung printr-o agentie imobiliara.

Astfel, in Bucuresti exista deja o scadere destul de masiva de apartamente pentru inchiriere, incat proprietarii prefera sa le pastreze pentru AirBnb si sa faca mai multi bani.  Acestia, listeaza apartamentele pe www.airbnb.com si intra in competitie directa cu hotelurile pentru piata de cazari.

De exemplu, in Bucuresti in luna Octombrie 2015 erau listate un nr de aprox 500 de unitati active din 900 total listate, care includ : camere private in apartamente in care dvs locuiti, studiouri, garsoniere, apartamente de 2 camere, 3 camere si 4+ camere.  Din acest total, majoritatea sunt garsoniere si studiouri (60%) si 14% apartamente de 2 camere.

Asta arata clar ca cererea din Bucuresti este clar directionata catre costuri mici pe noapte, insemnand undeva intre 30 si 80 euro / noapte.

 

Statistica pe nr de camere :

  • Studio, pret mediu pe 2015, 35$ / noapte
  • 1 dormitor, 37$ / noapte
  • 2 dormitoare, 55$ / noapte
  • 3 dormitoare, 88$ / noapte
  • 4 dormitoare sau mai mari de atat, 175$ / noapte

 

Statistica pe nr de oaspeti / inchiriere

  • 1 sau 2 oaspeti, 36$ / noapte
  • 3 sau 4 oaspeti, 50$ / noapte
  • 5 sau 6 oaspeti, 81$ / noapte

 

Ca sa tragem si o concluzie, la nivel de studio de exemplu, cu un nivel de inchiriere de 20 de nopti din 30 intr-o luna, ca sa nu exgeram, dvs puteti genera un venit de 35$ * 20 nopti = 750$ / luna ceea ce inseamna putin mai mult decat dublu unei chirii normale pe termen lung!

Asta inseamna ca daca va concentrati putin la acest business si va documentati cat sa alegeti bine apartamentele pe care le dati in productie, puteti face de 2 ori mai multi bani decat prin inchirierea normala pe termen lung si fara sa folositi nicio agentie imobiliara!!!

Daca in mod normal, puteti face un venit anual din chirii pe termen lung de 6-8% din pretul apartamentului, prin AirBNB, puteti ajunge la 15-18% in acelasi an!

Aveti grija totusi, cum alegeti apartamentele pe care le puneti pe AirBNB.  Acestea trebuie sa arate foarte bine, sa fie foarte curate, zona sa fie buna, centrala, intotdeauna aproape de guri de metrou, restaurante, suepermarketuri, etc.

AirBNB ajuta astfel proprietarii sa aiba un venit mai mare generat de aceeasi unitatate, in cazul in care aveti apartamentul potrivit, in locul potrivit si amenajat intr-un mod potrivit.

Celgene Corporation and Juno Therapeutics, Inc. Collaborates for Improved Commercialization of Immunotherapies

Celgene Corporation and Juno Therapeutics, Inc. announced a global collaboration for the development and commercialization of immunotherapies. The two companies will create T cell therapeutic strategies for treatments for patients with cancer and autoimmune diseases. Strategies will initially focus on Chimeric Antigen Receptor Technology (CAR-T) and T Cell Receptor (TCR) technologies.

CELGENE

The merger will allow Celgene an option to commercialize Juno programs outside North America and co-promote programs globally and on the other hand, Juno gains option to co-develop and co-promote select Celgene programs

According to the transaction, Celgene will make initial payment of approximately $1 billion which includes the purchase of ~9.1 million shares of Juno stock at $93.00 per share, with potential to increase its stake over time. A joint conference call scheduled today at 5:00 p.m. ET, 2:00 p.m. PT will further inform the public about the details of the merger transaction.

Bob Hugin, Chairman and CEO of Celgene mentioned in a statement, “This transaction strengthens Celgene’s position in the emerging and transformative area of immuno-oncology.” He also added, “Juno has assembled world class experts and built impressive capabilities and technologies in the areas of T cell biology and cellular therapy; we believe this long-term collaboration enhances the potential of both companies to deliver transformational therapies to patients with significant unmet medical needs.”

Hans Bishop, CEO of Juno also mentioned in a statement, “Celgene is the ideal partner for Juno to help us realize the full potential of our science and clinical research while maintaining the independence we, our employees, partners, and investors believe is so critical for true innovation.” He further explained, “This unique collaboration is designed to catalyze and create tremendous ongoing scientific and product development synergy by leveraging each company’s strengths and assets. In addition to its established global presence and commercial reach, Celgene has leading small molecule and protein capabilities that complement Juno’s advanced engineered T cell capabilities. By doing this together, we believe we can more quickly and effectively develop potentially disruptive therapies in this new field of medicine and make them more readily available to patients worldwide.”

Under the terms of the collaboration, Celgene has the option to be the commercialization partner for Juno’s oncology and cell therapy auto-immune product candidates. This includes Juno’s CD19 and CD22 directed CAR-T product candidates. B-Cell Maturation Antigen (BCMA) is excluded as a target in this collaboration.

Upon closing, Juno will receive an upfront payment of approximately $150 million, and in addition Celgene will purchase 9,137,672 shares of Juno’s common stock at $93.00 per share. This transaction has been approved by the boards of directors of both companies. Celgene and Juno currently expect to complete the transaction during the third quarter of 2015, subject to the expiration or termination of applicable waiting periods under all applicable antitrust laws and satisfaction of other usual and customary closing conditions.

About Celgene Corporation

Celgene Corporation is an American biotechnology company that manufactures drug therapies for cancer and inflammatory disorders. It is incorporated in Delaware and headquartered in Summit, New Jersey. The company’s major products are Thalomid (thalidomide), which is for the acute treatment of moderate to severe erythema nodosum leprosum (“ENL”) and Revlimid (lenalidomide), for which the company has received FDA and EMA approval for the treatment of multiple myeloma patients who have received at least one prior therapy. Celgene also receives royalties from Novartis Pharma AG on sales of the entire Ritalin family of drugs, which are widely used to treat Attention Deficit Hyperactivity Disorder (ADHD). Celgene stock market evolution: http://www.marketwatch.com/investing/stock/celg

About Bob Hugin

Mr. Hugin is the Chief Executive Officer of Celgene since June 2010 and Chairman since June 2011. He was previously President and Chief Operating Officer from May 2006 to June 2010, and was elected by the Board of Directors to serve as a Director in December 2001. Prior to joining Celgene, Mr. Hugin was a Managing Director with J.P. Morgan & Co. Inc. Mr. Hugin received an AB degree from Princeton University in 1976 and an MBA from the University of Virginia in 1985 and served as a United States Marine Corps infantry officer during the intervening period.

About Juno Therapeutics

JUNO

Juno Therapeutics is a clinical-stage company developing novel cellular immunotherapies based on two distinct and complementary platforms – Chimeric Antigen Receptors (CARs) and T Cell Receptors (TCRs) technologies. Our goal is to revolutionize medicine by re-engaging the body’s immune system to treat cancer. Juno Therapeutics stock market evolution; http://www.marketwatch.com/investing/stock/juno

About Hans Bishop

Hans Bishop is one of the co-founders of Juno Therapeutics and has served as Chief Executive Officer since Juno’s inception. Prior to this, he acted as Executive Vice President and Chief Operating Officer for Dendreon, a Seattle-based biotechnology company that develops immunotherapy products used in cancer treatment. Mr. Bishop previously held various positions at Glaxo Wellcome and SmithKlineBeecham. He serves on the Board of Directors of Avanir Pharmaceuticals. Mr. Bishop earned a B.S. in chemistry from Brunel University in London.

Novartis Agrees to Purchase Spinifex Pharmaceuticals for $200 Million Upfront

Swiss drug maker Novartis AG greatly improved its presence in pain management on Monday by agreeing to purchase U.S.-Australian biotech firm Spinifex Pharmaceuticals This was according to separate statements made by the two companies on Monday. Spinifex representatives said Novartis was paying $200 million upfront. This will allow Spinifex shareholders to get further payments based on clinical development and regulatory milestones. This transaction is expected to close in the second half of this year, pending regulatory approval.

novartis 2

The acquisition will allow Novartis to use Spinifex’s experimental neuropathic pain drug EMA401, which showed positive mid-stage Phase II clinical trial results for post-herpetic neuralgia (PHN). This is a painful condition that develops after a patient had shingles. The results of the clinical trials for EMA401 were published in The Lancet medical journal last year and it mentioned that there were no central nervous system side effects or any serious adverse events after the drug was administered.

Chronic neuropathic pain, from nerve problems, is a relatively common condition. This affects up to 7-8 percent of the adult population. But even with the increased prevalence of this condition, current treatment options are limited and can be problematic.

EMA401 is an amazing pain medication that acts outside the blood-brain barrier and thus it can avoid common side effects such as dizziness or confusion which are very often experienced by patients taking painkillers affecting the central nervous system. Novartis plans to continue the development of EMA401. It also intends to start Phase IIb clinical trials in patients with PHN a condition called painful diabetic neuropathy which affects people with diabetes.

The acquisition highlights the Swiss group’s drive to expand its new medicines at a time of growing investor confidence across the drugs sector.

David Epstein, head of Novartis Pharmaceuticals mentioned in a statement, “Neuropathic pain is a chronic and debilitating condition with high unmet need. EMA401 could provide a novel, differentiated treatment approach.”

Established in 2005 and based in Stamford, Connecticut and Melbourne, Australia, Spinifex is backed by venture capital groups including Novo A/S, Canaan Partners, GBS Venture Partners, Brandon Capital Partners, Uniseed and the University of Queensland.

Novartis on the other hand is in a strong position when it comes to recent advances with new drugs, including the heart failure medicine LCZ696 and a psoriasis injection called Cosentyx.

About Novartis International AG

Novartis International AG is a Swiss multinational pharmaceutical company with headquarters located in Basel, Switzerland. Novartis ranks number one in drug sales (57.9 billion US$) among the world-wide industry in 2013. Novartis manufactures such drugs as clozapine (Clozaril), diclofenac (Voltaren), carbamazepine (Tegretol), valsartan (Diovan) and imatinib mesylate (Gleevec/Glivec). Additional agents include cyclosporin (Neoral/Sandimmun), letrozole (Femara), methylphenidate (Ritalin), terbinafine (Lamisil), and others.

In 1996, Ciba-Geigy merged with Sandoz, and the pharmaceutical and agrochemical divisions of both companies formed Novartis. Other Ciba-Geigy and Sandoz businesses were sold, or like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for 3 years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Novartis divested its agrochemical and genetically modified crops business in 2000 with the spinout of Syngenta in partnership with AstraZeneca, which also divested its agrochemical business. Novartis International AG stock market evolution: http://www.marketwatch.com/investing/stock/nvs

About David Epstein

David Epstein is the Division Head of Novartis Pharmaceuticals at Novartis AG since 2010. He holds a BS Degree in Pharmacy with high honors from Rutgers University College of Pharmacy in 1984 and an MBA in Finance and Marketing from the Columbia University Graduate School of Business in 1987.

About Spinifex Pharmaceuticals

spinfex

Spinifex is a pioneer in the development of new treatments for chronic pain – a debilitating and often poorly treated condition that affects millions of patients all over the world. The demand for pain drugs continues to increase and this increases the growth of a market that is expected to be worth over US$35 billion by 2010. Spinifex’s lead programs are in neuropathic pain, due to nerve dysfunction. Spinifex is also targeting inflammatory pain such as that caused by osteoarthritis. A significant opportunity exists for new candidates that can deliver improved efficacy, side effect profiles, and time to onset and simplified dosing in chronic pain. EMA401, Spinifex’s lead clinical candidate, is being developed to address this unmet need and has successfully completed a Phase 2 clinical trial in post herpetic neuralgia (PHN), a neuropathic pain which follows herpes zoster (shingles) in some patients. In addition to PHN, EMA401 is being advanced as a potential treatment in other chronic pain indications and Spinifex has an active drug discovery program around its AT2 receptor antagonist technology.

General Cable Corporation Sells Asia Pacific Operations to MM Logistics Co., Ltd.

General Cable Corporation announced a definitive agreement to sell its Asia Pacific operations to MM Logistics Co., Ltd. for cash consideration of approximately $205 million. This transaction includes preliminary estimated net cash of $30 million available at the closing of the purchased businesses and is subject to customary working capital adjustments at the respective closing dates.

General Cable

General Cable’s Asia Pacific operations consist of businesses in Thailand, China, New Zealand and Australia. The Company expects to close the sale of the operations in the third quarter, subject to customary closing conditions. Proceeds of the sale are expected to be used to reduce outstanding borrowings and pay related fees and expenses.

John E. Welsh, III, Chairman of the Board of General Cable, mentioned in a statement, “We are pleased with the continued execution and positive momentum we have achieved in our divestiture program that we originally announced last October.” He also said, “This agreement to sell our Asia Pacific operations represents another significant step to simplifying our geographic portfolio and reducing organizational complexity. We remain focused on the divestiture process for our businesses in Africa which are advancing according to plan. We are also optimizing our business, reducing costs and driving efficiencies in our core markets in North America, Latin America and Europe as we continue to execute our restructuring program.”

Brian J. Robinson, Executive Vice President and Chief Financial Officer said, “We previously completed the sale of our interests in Phelps Dodge International Philippines, Inc., Keystone Electric Wire and Cable (China), and Dominion Wire and Cables (Fiji) which together represented approximately $88 million of cash proceeds. Upon completion of the sale of our operations in Thailand, China, New Zealand and Australia for an estimated $205 million of cash consideration, the Company will have generated approximately $293 million of cash proceeds from its divestiture program which is consistent with our previously communicated expectations.”

HSBC is the financial adviser to General Cable on the sale of its Asia Pacific operations (which includes China, Thailand, Australia and New Zealand). Credit Agricole Corporate and Investment Bank acted as co-financial adviser on the sale of General Cable’s operations in China.

About General Cable

General Cable is a company based in Highland Heights, Kentucky. It has offices and manufacturing facilities in several countries, that manufactures and distributes copper, aluminum, and optical fiber cables used for energy, communications, and other industries. General Cable was incorporated in New Jersey in 1927, merging several older companies founded in the 19th century, including Phillips Wire and Safety Cable Company, Rome Wire Company, and Standard Underground Cable. In 2013, General Cable was ranked by Fortune Magazine as the 425th largest U.S. public company with $6,014.3 million in revenue

General Cable produces copper, aluminum, and fiber optic wire and cable products for the energy, construction, industrial, specialty and communications markets. The company’s energy cables include low-, medium- and high-voltage power distribution and power transmission products. General Cable’s application-specific industrial and specialty cables are used in electrical power generation — traditional and renewable — the oil, gas and petrochemical industries; mining; industrial automation; automotive, marine, and transit; and military, aerospace and OEM applications. General Cable sells its products under several brands including Anaconda; GenSPEED; BICC; Brand Rex; Carol; Gepco; NextGen; NSW; PDIC; Phelps Dodge International Corporation; and Silec. General Cable stock market revolution http://www.marketwatch.com/investing/stock/bgc

About John E. Welsh III

Mr. John E. Welsh III is Chairman of the Board for General Cable Corp. since 2001. He is also the President of Avalon Capital  Partners, LLC and Managing Director of CIP Management LLC. He received a BS in Economics and Finance from Lehigh University and an MBA in Finance from the Wharton School of Business, University of Pennsylvania.

About MM Logistics

MM logistics
MM Logistics’ mission is to provide real added value for its principals, customers and employees, MM Logistics & MML Transport concentrates on premium quality of services in the specific sector of logistic support in the oilfield business. MM Logistics & MML Transport believes strongly in the concept of global cooperation and in educating and stimulating Thai nationals to take part in this process and to give them the opportunity to equal, grow and prosper.

MM Logistics is one of MMSVS Group company. It was established in 1999. And most of its employee used to provide Customs Clearance and Transport Contract to support PTTEP Bongkot Operations from 1990 to mid-1998. MM Logistics was ISO9001:2000 certified since 2002. It has long experience in providing Customs Clearance, Ship Clearance, Transportation, Lifting Equipment Service, Warehouse Rental and Cargo Forwarding Service.

About Brian J. Robinson

Mr. Brian J. Robinson has been the Chief Financial Officer of General Cable Corp. He is also the Chief Financial Officer, Executive Vice President and Treasurer at Alcan Products Corporation. Mr. Robinson holds a Bachelor of Science degree in Accounting from the University of Dayton and received his Certified Public Accountant certification in 1993.

GigaMedia Has Acquired 70% Interest in Strawberry Cosmetics Holding Limited for US$93.1 Million

GigaMedia announced that it has entered into a share purchase agreement to acquire a 70% equity interest in Strawberry Cosmetics Holding Limited. Strawberry Cosmetics is a global cosmetics e-commerce company. The total consideration payable by the Company for the acquisition is approximately US$93.1 million.

giga

Strawberry Cosmetics is an established online distribution and retail platform of beauty products. The company owns and operates the website “StrawberryNET.com” and the site’s related mobile application. Strawberry Cosmetics has a comprehensive sales and distribution network with customers in all the major countries all over the world.

StrawberryNET.com is translated into 38 languages, and has a customer base of over 3 million customers worldwide. It also has also established a global sourcing network of a comprehensive range of beauty products with more than 700 brands and 30,000 stock keeping units.

Consolidated sales revenues of Strawberry Cosmetics as well as its subsidiaries in the recent four years have been over US$200 million per year. The revenue contribution is mainly from its sales in the Oceania, United States and European markets. The Asian market on the other hand is still in the process of growth. Strawberry Cosmetics will benefit from the Company’s existing marketing resources for further expanding its Asian market. It will also benefit from the GigaMedia’s technology expertise for enhancing its future product strategy.

Strawberry Cosmetics is an established and proven e-commerce platform with existing customer base. The transaction would help diversify the Company’s overall business risks and improve the Company’s business portfolio in the Internet and technology sector. This will also allow the Company to tap into the fast growing beauty and cosmetics e-commerce market.

GigaMedia sees potential significant synergies with Strawberry Cosmetics from leveraging the its expertise in information technology, online and offline marketing, as well as its local connections in various Asian countries including China, Japan and South Korea. The completion of the Transaction is subject to the Company’s shareholders’ approval at an extraordinary general meeting of shareholders to be held on August 5, 2015 and other customary conditions. The Transaction is expected to be completed in the third quarter of 2015.

About GigaMedia Limited

GigaMedia Limited is a major provider of online entertainment software and services. Headquartered in Taipei, GigaMedia is a holding company with a diversified portfolio of businesses providing online games and cloud computing services.

GigaMedia develop software for online entertainment services, including the global online gaming market. GigaMedia’s FunTown game portal is a leading Asian casual games portal and the world’s largest online Mahjong game site in terms of revenue. FunTown generates revenues through access fees and also through the sales of various in-game items. It was founded in 1998 by the Acer computer company. They are based in Greater China, with offices in Shanghai, Hong Kong, and Taiwan. GigaMedia also operate the EverestPoker.com poker site.

GigaMedia’s online games business develops and operates a suite of games in Taiwan and Hong Kong, with focus on extending Giga’s online games platform to Web/mobile games, the fastest growing segment of online games, and supporting cross-platform play with strong self-development capabilities. On the other hand, the company’s cloud computing business is focused on providing SMEs in Greater China with critical communications services and IT solutions that increase flexibility, efficiency and competitiveness.

GigaMedia was incorporated in September 1999 as a company limited by shares organized under the laws of the Republic of Singapore, and completed an initial public offering of its shares on NASDAQ on February 24, 2000. GigaMedia stock market evolution: http://www.marketwatch.com/investing/stock/gigm

About Strawberry Ltd.

Strawberry Ltd. Is a skin care company that provides skincare, makeup and fragrance products online. It also provides hair care products, women’s and men’s fragrances, cosmetics, perfumes and colognes worldwide. Strawberry Ltd. was founded in 1996 and is based in Shau Kei Wan, Hong Kong. With over 10 years in business and backed by a dedicated team devoted to improving your shopping experience, we’re proud to call ourselves “The Fresh Cosmetic Company” because we’re innovative and modern with a determination to become the leader in the future of ‘E’Tailing. The company is the first truly global offer of branded products at a discounted price and they believe in providing a hassle-free environment to purchase favorite skincare, makeup and fragrances at prices that customers can easily afford. With over 30,000 items from over 750 brands, it has the largest discount range available in the world of Make Up, Skincare and Fragrance, all at hugely discounted prices

All of Strawberry Cosmetics products are fresh and genuine brand items and their special offers are very irresistible. Strawberry Cosmetics is a totally international company that purchases all genuine products duty free and delivers anywhere in the world. It has hundreds of thousands of satisfied customers in over 200 countries worldwide.

Sabra Health Care REIT Purchases Four Transitional Care Facilities in Maryland

Sabra Health Care REIT has agreed to purchase a portfolio of four transitional care facilities located in Maryland. Four skilled nursing facilities that specialize in transitional care and medically complex post-surgical, ventilator and dialysis patients are included in the transactions, collectively called “NMS Portfolio,” located in Maryland for $234 million.

Sabra

Upon completion of the acquisition, Sabra and the current operator will have a triple-net master lease agreement on three of the facilities and a triple-net lease agreement on the fourth facility which is encumbered by a HUD loan. Each of the master lease and the lease for the fourth facility will have an initial term of 15 years with two 10-year renewal options and annual rent escalators equal to the greater of 2.50% or CPI, but not to exceed 2.75%.

The leases are collectively expected to create an annual lease revenue determined in accordance with GAAP of $24.5 million and an initial yield on cash rent of 8.75%. Closing on the acquisition of three of the facilities, with an allocated purchase price of $175.2 million, is expected to occur on or before June 30, 2015. The fourth facility is expected to close upon the assumption of an existing $10.8 million HUD loan having an interest rate of 5.60% per annum.

The closing of the acquisition of the NMS Portfolio is subject to customary conditions, including the satisfactory completion by Sabra of its due diligence and, as to the fourth facility, the HUD loan assumption. In addition to the HUD loan assumption, Sabra expects to fund the remainder of the acquisition with available cash and proceeds from their revolving credit facility.

Rick Matros, CEO and Chairman, mentioned in a statement, “The Canadian acquisition we recently announced reduced our skilled nursing exposure to approximately 50%, opening up the opportunity for us to look more seriously at skilled nursing acquisitions. The NMS Portfolio will only increase that exposure to 55.9%, and our intent is to maintain our skilled nursing exposure at or around 50%. We had first looked at this portfolio a few years ago and were very impressed with the team. Their focus was and is on short stay post-surgical patients and longer term complex medical patients requiring ventilator care and other complex conditions. They’ve continued to build on that capability since we were first introduced to them. The State of Maryland, like numerous other states, has specialized Medicaid rates for complex medical patients that approximate Medicare rates so the operating team can access Medicare, Managed Care and non-traditional Medicaid reimbursement sources for these services. Other operators in our portfolio do the same in select states.”

Mr. Matros also added, “Currently, there is a small percentage of operators in the skilled nursing sector that have strategically moved their model in this direction which we believe to be the future of the business. Over time that number will increase. We are fortunate to have quite a few operators in our portfolio whose business model reflects ‘the new world order’ including the Vision portfolio we acquired in the 4th quarter of 2014. Genesis is moving in that direction with their PowerBack model. Our focus is to populate our skilled nursing portfolio with more of this higher end model.”

Delhaize Group and Royal Ahold N.V. Combine to Create Ahold Delhaize

Delhaize Group and Royal Ahold N.V. (Ahold) today announced that they have entered into an agreement to merge. The combined company will be named Ahold Delhaize and this will have a portfolio of trusted local brands. Ahold Delhaize will have more than 375,000 associates serving more than 50 million customers weekly in the United States and Europe.

Delhaize

Because of the amazing advantages from each of the two companies, the combined company will have enhanced scale across regions and will have leading market retail offerings. Ahold Delhaize will also benefit from the strong heritage and values of both companies.

Jan Hommen, Chairman of Ahold, and Mats Jansson, Chairman of Delhaize, said: “This is a true merger of equals, combining two highly complementary businesses to create a world-leading food retailer. The transaction delivers a compelling value proposition for our shareholders, a superior offering for our customers and attractive opportunities for our associates.”

Frans Muller, CEO of Delhaize, said: “We believe that the proposed merger of Ahold and Delhaize will create significant value for all our stakeholders. Supported by our talented and committed associates, Ahold Delhaize aims to increase relevance in its local communities by improving the value proposition for its customers through assortment innovation and merchandising, a better shopping experience both in stores and online, investments in value, and new store growth. We look forward to working closely with the Ahold team to implement a smooth integration process and realize the targeted synergies.”

Dick Boer, CEO of Ahold, said: “The proposed merger with Delhaize is an exciting opportunity to create an even stronger and more innovative retail leader for our customers, associates and shareholders worldwide. With extraordinary reach, diverse products and formats, and great people, we are bringing together two world-class organizations to deliver even more for the communities we serve. Our companies share common values, proud histories rooted in family entrepreneurship, and businesses that complement each other well. We look forward to working together to reach new levels of service and success.”

The merger will take place through a cross-border legal merger of Delhaize into Ahold. Included in the transaction, Delhaize shareholders will receive 4.75 Ahold ordinary shares for each Delhaize ordinary share. Ahold will terminate its ongoing share buyback program; €1 billion will be returned to Ahold shareholders via a capital return and a reverse stock split prior to completion of the transaction

Ahold Delhaize will be listed on the Amsterdam Stock Exchange and the Brussels Stock Exchange. Delhaize’s ADS program will be terminated at completion and Delhaize ADS holders will have the choice to receive either Ahold ADRs under the current Ahold OTC ADRs program or Ahold Delhaize ordinary shares. Pending shareholder approvals and regulatory clearance, as well as other customary conditions, the deal is expected to complete mid-2016

About Delhaize

Delhaize Group is a food retailer headquartered in Anderlecht, Brussels, Belgium which operates in seven countries and on three continents. The principal activity of Delhaize Group is the operation of supermarkets. In June 24, 2015, Delhaize Group reached an agreement with Royal Ahold to merge. Forming a Parent Company of Ahold Delhaize. Delhaize stock market evolution: http://www.marketwatch.com/investing/stock/deg

About Mats Jansson

Mr. Jansson has served as Chairman of the Board of Directors of Delhaize since May 24, 2012. He also previously served as a director of Axfood, Mekonomen, Swedish Match, Hufvudstaden and Danske Bank. Mr. Jansson studied economical history and sociology at the University of Örebro.

About Frans Muller

Mr. Muller is President and CEO of Delhaize Group since November 8, 2013. In 1988, he joined KLM Cargo where he served in various management and executive positions in Amsterdam, Frankfurt, and Vienna, Singapore. Muller holds a Master of Business Economics from the Erasmus University, Rotterdam (The Netherlands).

About Ahold

ahold

Koninklijke Ahold N.V. is a Dutch international retailer based in Zaandam, The Netherlands. Ahold is an AEX-listed company on NYSE Euronext Amsterdam. The company started in 1887, with the founding of an Albert Heijn grocery store in Oostzaan, The Netherlands. The grocery chain expanded through the first half of the 20th century, and went public in 1948. In June 24, 2015, Delhaize Group reached an agreement with Royal Ahold to merge. Forming a Parent Company of Ahold Delhaize. Ahold stock market evolution: http://www.bloomberg.com/quote/AH:NA0

About Jan Hommen

Jan Hommen is the Chairman of the Selection and Appointment Committee of Ahold. He was appointed to the Supervisory Board at the General Meeting of Shareholders on April 2013. He is the former CEO of ING Group N.V., former CFO and vice chairman of the board of management of Royal Philips Electronics N.V. and former CFO of Aluminum Company of America.

 

About Dick Boer

Mr. Dick Boer has been the Chief Executive Officer of Koninklijke Ahold N.V since March 1, 2011 and serves as its President. Mr. Boer serves as the Chairman of Management Board and President of Koninklijke Ahold N.V. He studied Executive MBA at program IBO (Zeist).

3M Acquires Capital Safety from KKR for $2.5 Billion

3M and Capital Safety from KKR have entered into a definitive agreement. 3M acquires Capital Safety and this acquisition has a total enterprise value of $2.5 billion, including the assumption of approximately $0.7 billion of debt.

3m

Capital Safety is a leading provider of fall protection equipment in the world. This is one of the fastest-growing safety categories in global personal protective equipment industry. The personal protective equipment industry is very important to 3M simply because the demand for personal protective equipment is rapidly growing.

Some of the personal safety products and solutions that are developed by Capital Safety include harnesses, lanyards, self-retracting lifelines and engineered systems sold under well-known global brands DBI-SALA and PROTECTA.

On the other hand, 3M’s Personal Safety business which is a part of 3M’s Safety and Graphics Business Group is provider of respiratory and hearing protection solutions that help improve the safety and security of workers. Aside from these there are also reflective materials for high-visibility apparel, protective clothing and eyewear.

Inge G. Thulin, 3M chairman, president and chief executive officer, mentioned in a statement “Personal safety is a large and strategically important growth business in the 3M portfolio.” He said. “The acquisition of Capital Safety bolsters our personal safety platform and will build on our fundamental strengths in technology, manufacturing, global capabilities and brand.”

Pete Stavros, member of KKR and head of the Industrials team, mentioned in a statement “We have had an absolutely fantastic partnership with the management and employees of Capital Safety. Over the past three years, the company has driven impressive top-line growth, broadened its geographic presence and further optimized its operations. Today, Capital Safety is a clear global leader in fall protection.” He said, “3M is a perfect home for a company and team that is so deeply committed to safety.”

Stephen Oswald, chief executive officer, Capital Safety, said “This is a great strategic fit and provides Capital Safety and its employees with a strong platform for future growth. Each company also highly values innovation and this will enable us to drive further product development and provide a broader array of solutions to both Capital Safety and 3M customers.”

3M estimates the acquisition to be $0.04 dilutive to earnings in the first 12 months following completion of the transaction. This excludes purchase accounting adjustments and anticipated one-time expenses related to the transaction and integration, 3M estimates the acquisition to be $0.12 accretive to earnings over the same period. The effective enterprise value multiple is approximately 14 times annual adjusted EBITDA for the first 12 months following the completion of the transaction.

The transaction is expected to close in the third quarter, subject to customary closing conditions and regulatory approvals. 3M will finance the transaction with existing cash, a portion of which will come from outside the U.S.

About 3M

The 3M Company, formerly known as the Minnesota Mining and Manufacturing Company, is an American multinational conglomerate corporation with headquarters in St. Paul, Minnesota. 3M employs 88,000 people worldwide and produces more than 55,000 products, including: adhesives, abrasives, laminates, passive fire protection, dental and orthodontic products, electronic materials, medical products, car-care products, electronic circuits, and optical films. 3M has operations in more than 65 countries including 29 international companies with manufacturing operations and 35 companies with laboratories. 3M stock market evolution: http://www.marketwatch.com/investing/stock/mmm

About Capital Safety

Capital safety

Capital Safety is a manufacturer of fall protection, confined space, and rescue equipment for oil and gas, construction, utilities, wind energy, transportation, telecommunication, mining, and general industries. Capital Safety also provides in-house and on-site fall protection and rescue training services. It partners with insurance providers to hold 4-hour to 5-day safety training classes. Capital Safety is based in Bloomington, Minnesota. Capital Safety stock market evolution http://finance.yahoo.com/q?s=KKR

About Inge Thulin

Mr. Inge Thulin is the Executive Vice President and Chief Operating Officer of 3M Company. He holds an MBA in Economics and Marketing from Gothenburg University / IHM Business School, Gothenburg, Sweden School of Economics and Commercial Law in 1978. He received a DHIM degree in Marketing and Strategy from Gothenburg University’s IHM Business School in Gothenburg, Sweden.

About Stephen G. Oswald

Mr. Stephen G. Oswald has been Chief Executive Officer of Capital Safety, Inc.  Since March 201, Mr. Oswald oversees Capital Safety’s global operations, which includes 20 manufacturing, distribution and training facilities worldwide. Mr. Oswald holds an MBA from the University of Chicago. He also holds a Master’s degree in Industrial Engineering from the University of Cincinnati and a Bachelor’s Degree in Industrial Engineering from Polytechnic University in Brooklyn, New York. He is a graduate of GE’s Manufacturing Management Program.

About Pete Stavros

Pete Stavros is a Partner, Head of the Industrials investment team, and member of the Investment Committee within KKR’s Private Equity platform in the Americas. He holds an A.B. and B.S., magna cum laude, from Duke University and an M.B.A. with high distinction, Baker Scholar, from Harvard Business School. Mr. Stavros is a member of the Board of Visitors at the Fuqua School of Business at Duke University.

Home Properties To Be Acquired by Affiliate of Lone Star Funds for $7.6 Billion

Home Properties announced that it has entered into a definitive agreement to be acquired by an affiliate of Lone Star Funds. This transaction was valued at approximately $7.6 billion and this includes Home Properties existing debt. Upon completion of the transaction, Home Properties will become a privately held company.

Home properties

Lone Star Funds will purchase all of the outstanding common stock of Home Properties for $75.23 per share in an all-cash transaction. The offer price represents a premium of approximately 9% over Home Properties’ unaffected closing stock price on April 24, 2015, the last trading day prior to media reports on a potential transaction, and a premium of approximately 11% over the average closing price of Home Properties’ common stock for the 60 days ended April 24, 2015.

Edward J. Pettinella, President and Chief Executive Officer of Home Properties, mentioned in an interview: “The Home Properties team has built a great company, as reflected by our strong platform, unique assets, and differentiated business strategy.” He added, “We believe this transaction with Lone Star Funds provides our stockholders with compelling value for their investment, consistent with our long-term strategy.”

Hugh J. Ward III, Co-Head of Real Estate Investments at Lone Star Funds, added, “We are pleased to enter into an agreement to acquire Home Properties and look forward to working with their talented team to complete this transaction and integrate the Company’s portfolio into Lone Star Funds’ existing multifamily portfolio. This is Lone Star Funds’ second large, recent apartment purchase following the 2014 acquisition of a 64 property, 20,439 unit portfolio, and is consistent with our strategy of buying primarily Class B apartments, including workforce housing, located in in-fill markets with strong underlying fundamentals.”

Before the Home Properties Merger will be enacted and pursuant to the Merger Agreement, Lone Star Funds will acquire all of the Home Properties OP Units that are not owned by Home Properties and have not been exchanged as described above pursuant to a merger of Home Properties OP with a wholly owned subsidiary of Lone Star Funds. In connection with the OP Merger, holders of Home Properties OP Units that have not exchanged OP Units as described above will receive $75.23 per unit in cash upon the closing of the OP Merger.

Tom Toomey, President and Chief Executive Officer of UDR, also mentioned, “We appreciate Home Properties and Lone Star Funds reaching out to create an opportunity for UDR to offer the Home Properties OP Unitholders an alternative that will allow them to continue to participate in the strong multifamily space and continued growth in UDR.”

Approvals, Anticipated Closing The Board of Directors of Home Properties have unanimously approved the merger agreement and have recommended approval of the Home Properties Merger by the Home Properties stockholders and of the Home Properties OP Merger by the Home Properties OP unitholders.

The transaction is expected to close during the fourth quarter of 2015, subject to the approval of the Home Properties Merger by the Home Properties stockholders and the approval of the Home Properties OP Merger by the Home Properties OP unitholders.

About Home Properties

Home Properties, Inc. is a publicly traded apartment real estate investment trust that owns, operates, develops, acquires and rehabilitates apartment communities primarily in selected Northeast and Mid-Atlantic markets. It operates over 38,000 apartment units. The company is headquartered in Rochester, New York. Home Properties, Inc. stock market evolution http://www.marketwatch.com/investing/stock/hme

About Edward Pettinella

Mr. Edward J. Pettinella is President, Chief Executive Officer, Director of Home Properties Inc., since January 1, 2004. He is also a Director. He joined the Company in 2001 as an Executive Vice President and Director. He is also a Board member of Rochester Business Alliance, National Multi Housing Council and Syracuse University, as well as a member of ULI and NAREIT. Mr. Pettinella is a graduate of the State University of New York at Geneseo and holds a Masters in Business Administration degree in Finance from Syracuse University.

About Lone Star Funds

Lone star

Lone Star Funds is a private equity firm that invests in distressed assets both in the United States and internationally. The founder established its first fund in 1995 (under a different name) and Lone Star has to date organized fifteen private equity funds with total capital commitments since inception of over $59 billion (as of June 2015). Lone Star’s investors include corporate and public pension funds, sovereign wealth funds, university endowments, foundations, fund of funds and high-net-worth individuals. Lone Star Funds has affiliate offices in North America, Europe and Japan.

About Hugh J. Ward III

Hugh J. Ward III is the Senior Managing Director and Co-Head of Real Estate Investments at Lone Star Funds

Sequential Brands Acquires All Outstanding Shares of Martha Stewart Living Omnimedia, Inc.

Sequential Brands has signed a definitive merger agreement to acquire 100% of the outstanding shares of Martha Stewart Living Omnimedia, Inc. The Merger improves Sequential’s platform, which is expected to generate nearly $3.75 billion in annual global retail sales from a combined categories of consumer brands.

Sequential

The terms of the merger agreement have been approved by the boards of directors of both companies. It states that Martha Stewart will continue to be an integral part of the brand that she founded and will serve as Chief Creative Officer. Ms. Stewart will become a significant stockholder of the new public holding company of Sequential and MSLO and will be nominated to serve on its board of directors as of the closing.

Founder Martha Stewart mentioned in a statement “This is a transformational merger for Martha Stewart Living Omnimedia, the company I founded in 1997. This merger is positioned to further the growth and expansion of the unique Martha home and lifestyle brand. In 1991, I started a magazine, Martha Stewart Living, which was the first of its kind. Out of our groundbreaking editorial content grew an influential brand which quickly evolved into other media, merchandising and digital platforms and products which have helped consumers, worldwide, live better, more fulfilling lives.” She also said, “With our media business operations now successfully transitioned to Meredith, we now have the opportunity to tap into Sequential’s expertise and resources to expand our merchandising business both domestically and abroad. The Sequential team is smart, hardworking, and understands the power and limitless opportunity of the Martha Stewart brand and its formidable design, editorial and marketing teams. I’m looking forward to working with them.”

Yehuda Shmidman, CEO of Sequential, commented, “Martha Stewart’s impact around the world is staggering, and the empire she founded is unmatched in its industry. In fact, research shows that the Martha Stewart brand has 96% awareness among women in the U.S. and 7 out of 10 women say that Martha has and does influence the way they think about, organize, and manage their homes. Looking ahead, we believe that we can leverage our global activation platform at Sequential in partnership with Martha and her team to develop the next chapter of growth for the Martha Stewart brand. We are honored to have this opportunity and thrilled to be working together with Martha Stewart.”

Martha Stewart Living Omnimedia is a leading provider of the earliest versions of “how-to” information. The company has also inspired consumers with unique lifestyle content and high-quality products. MSLO has approximately 100 million consumers across all media platforms each month and has a growing retail presence in thousands of locations with leading retailers such as Macy’s, The Home Depot, PetSmart, Michaels and Staples. It has earned multiple national magazine awards, 19 Emmys, 4 James Beard Awards, several Webby Awards and more.

William Sweedler, Chairman of Sequential, stated, “This transformational acquisition marks an incredible milestone for Sequential as it not only delivers on the vision we put in place when we founded Sequential, but also sets the stage for the Company’s next phase of growth. Once we close, our run rate will surpass our published three year financial plan, and we will be set up to publish a new three year financial plan that is more than double our current goals for both revenue and adjusted EBITDA.” Mr. Sweedler added, “I look forward to Martha Stewart joining our Board of Directors and I’m excited for our future.”

Dan Dienst, Chief Executive Officer of MSLO also mentioned, “I am truly proud of the hard work that has been done by the team at MSLO, particularly over the past 18 months, to take our iconic, peerless American brand that Martha Stewart has built into its next phase of growth.” He also said, “Against the backdrop of Martha’s vision, an invigorated, strong and competitive MSLO and the new partnership with Sequential and its leadership team, I am excited to help execute on this next chapter of shareholder wealth creation.”

The acquisition, which is expected to close in the second half of 2015 is subject to customary closing conditions and approval by the holders of a majority of the MSLO outstanding common stock not owned directly or indirectly by Martha Stewart or her affiliates. The Company will provide further details on plans for the newly acquired family of brands and financial impact associated with today’s announcement when the transaction is completed.

About Sequential Brands Group, Inc.

Sequential Brands Group, Inc. owns, promotes, markets, and licenses a portfolio of consumer brands to retailers, wholesalers, and distributors in the United States and internationally. It licenses brands in the apparel, footwear, eyewear, and fashion accessories, including Avia, AND1, Ellen Tracy, Revo, Caribbean Joe, DVS, and The Franklin Mint. Sequential Brands Group, Inc. was incorporated in 1982 and is headquartered in New York, New York. Sequential Brands Group stock market evolution: https://finance.yahoo.com/q/pr?s=SQBG+Profile

About Yehuda R. Shmidman

Yehuda R. Shmidman is the President at SBG Universe Brands, LLC. He has been the Chief Executive Officer of Sequential Brands Group, Inc. since November 2012. He has been named in the “40 Under 40” list by Crain’s New York. He has a Bachelor’s Degree in Political Science from Yeshiva University.

About William Sweedler

Mr. William Sweedler serves as the Chairman of the Board of Sequential Brands Group, Inc. Mr. Sweedler was appointed to the Board of Directors in connection with financing transaction

About Martha Stewart Living Omnimedia Inc.

Martha Stewart Living Omnimedia Inc. is a diversified media and merchandising company founded by Martha Stewart. It is organized into four business segments: Publishing, Internet, Broadcasting media platforms, and Merchandising product lines. MSLO’s business holdings include a variety of print publications, television and radio programming, and e-commerce websites. MSLO stock market evolution http://www.marketwatch.com/investing/stock/mso

About Martha Stewart

Martha

Martha Helen Stewart is an American businesswoman, writer, and television personality. As founder of Martha Stewart Living Omnimedia, she has gained success through a variety of business ventures, encompassing publishing, broadcasting, merchandising, and electronic commerce. She has written numerous bestselling books and hosted two long-running syndicated television shows, Martha, which ran from 2005 to 2012, and Martha Stewart Living, which ran from 1993 to 2005.

About Daniel W. Dienst

Daniel Dienst has been the Chief Executive Officer of Martha Stewart Living Omnimedia Inc. since October 2013. He is a graduate of Washington University and received a J.D. from The Brooklyn Law School.

Medtronic Acquires CardioInsight Technologies, Inc. to Become Part of Medtronic Atrial Fibrillation Solutions

Medtronic announced that it has acquired CardioInsight Technologies, Inc., a privately-held, medical device company based in Cleveland that has developed a unique strategy to improve the mapping of electrical disorders of the heart. CardioInsight will now become a part of the Medtronic Atrial Fibrillation Solutions business in the Cardiac Rhythm and Heart Failure division.

Medtronic2

Medtronic has finished its acquisition of CardioInsight on a debt-free basis in a transaction worth approximately $93 million, net of CardioInsight’s cash of $7 million, plus performance-based contingent consideration completed post-closing. The transaction includes an initial cash payment of $75 million and retirement of a Medtronic loan outstanding to CardioInsight in the amount of $25 million. Other details about the acquisition were not disclosed

Reggie Groves, vice president and general manager of the AF Solutions business, mentioned in a statement: “This investment aligns with our goal to deliver breakthrough technologies for patients who have atrial fibrillation and other arrhythmias.” He said “CardioInsight will broaden and enhance the existing AF Solutions program at Medtronic, and will provide meaningful clinical and economic solutions for patients, hospitals, physicians and payers.”

The CardioInsight ECVUE(TM) system is the company’s latest technology that non-invasively generates images of the electrical activity of the heart through the use of body surface electrical data with 3-dimensional (3-D) anatomical data. The 3-D maps gathered are reconstructed along with other useful measures of cardiac electrical activity. The ECVUE system has been used with more than 1,400 patients in Europe and the U.S. It has been widely acclaimed and in fact it was also featured in more than 120 peer reviewed journals and presentations.

Medtronic will include revenue from the CardioInsight product line as part of the Cardiac Rhythm and Heart Failure division within the Cardiac and Vascular Group. This acquisition is deemed to meet Medtronic’s long-term financial metrics, and the annualized earnings impact of this acquisition is not expected to be material. Along with leading clinicians, researchers and scientists worldwide, Medtronic offers the broadest range of innovative medical technology for the treatment of cardiovascular disease and cardiac arrhythmias.

About Medtronic

Medtronic plc is an Irish company with its principal executive office located in Ireland and its operational headquarters is in suburban Minneapolis, Minnesota. It is the world’s third largest medical device company. In 2015, at the time of its acquisition of Covidien, Medtronic’s market cap was about $100 billion while the market cap for CRH, Ireland’s largest indigenous business, was $18.4 billion. Medtronic operates in more than 140 countries. The company employs more than 85,000 people and has more than 53,000 patents

Medtronic was founded in 1949 in northeast Minneapolis by Earl Bakken and his brother-in-law Palmer Hermundslie as a medical equipment repair shop. They originally planned on selling basketball pumps due to a shortage in the Midwest in the 20th century. In June 2014, Medtronic announced its acquisition of Covidien, PLC of Ireland for $42.9 billion. Following the acquisition, Medtronic ceased to be a Minnesota-based company, officially renamed Medtronic PLC and headquartered in low-tax Ireland. Medtronic stock market evolution http://www.marketwatch.com/investing/stock/mdt.

About CardioInsight

Cardioinsight

CardioInsight is a Cleveland, Ohio based medical device company that has developed a non-invasive advanced cardiac mapping technology to map electrical disorders of the heart. The technology uses body surface electrical data with heart and torso anatomy to provide single beat epicardial 3D electroanatomic maps of the heart. The technology was initially developed by Yoram Rudy, Ph.D. while he was Director of Cardiac Bioelectricity Research at Case Western Reserve University in Cleveland, Ohio. CardioInsight ECVUE™ system is the first, non-invasive mapping system to provide simultaneous, 3D, multi-chamber mapping and localization of cardiac arrhythmia mechanisms. It uses a proprietary, single-use, disposable multi-sensor “vest” to capture electrical signals from the body surface, and sophisticated software to compute and visualize epicardial 3D electroanatomic maps and virtual electrograms from the heart. This system is the first advanced mapping technology to non-invasively generate 3D electrical maps of the heart in a single beat, thus providing the unique opportunity to enable advanced cardiac mapping.

 

About Reggie Groves

Reggie Groves is the Vice President and General Manager at Medtronic. Through Mr. Groves, Medtronic has expanded global entry plans for the Launch/re-launch products in over 97 countries globally, including engaging key industry thought leaders, working with the government to avoid a local clinical trial, and designing a go-to-market plan which resulted in exceeding plan performance. Prior to being the VP and GM, Mr. Groves was the Vice President for Quality and Regulatory and Vice President and General Manager for Patient Management. Before he worked for Medtronics, he was Global Managing Partner for Scient, Inc. Mr. Groves earned his Master of Business Administration at Harvard Business School and Bachelor’s degree, Pharmacy at the University of Florida.

Can–Fite BioPharma Announces OphthaliX’s Acquisition of Improved Vision Systems Ltd.

Can-Fite BioPharma has announced that its subsidiary, OphthaliX has signed a definitive agreement to purchase Improved Vision Systems Ltd. an Israel-based company. According to the agreement OphthaliX will issue to the sellers and option holders of I.V.S. at the initial closing such number of shares of OphthaliX common stock and OphthaliX options which are equal to an aggregate of approximately 14% of the issued and outstanding capital stock of OphthaliX on a fully diluted basis. This is immediately following the initial closing.

Can Fite

According to the transaction, OphthaliX has agreed to issue to the sellers and option holders of I.V.S. such number of shares of OphthaliX common stock and OphthaliX options which is also equal to an aggregate of approximately 11% of the issued and outstanding capital stock of OphthaliX on a fully diluted basis upon the attainment of certain milestones.

The closing of the acquisition is subject to certain closing conditions including the raising of capital by OphthaliX and an up-listing of OphthaliX to a national securities exchange in the United States. No shares of OphthaliX’s parent company, Can-Fite BioPharma, are included in this acquisition transaction.

Improved Vision Systems creates breakthrough medical device technologies that aims to improve sight, diagnose and offer therapy for a variety of ocular diseases such as glaucoma, age related macular degeneration (AMD), diabetic retinopathy and oculo-motor pathologies. The company is also developing an indoor eye tracking solution, attachable to any screen including TVs, computers, tablets, etc., that manipulates the image shown to the user in such a way as to best compensate for such user’s specific clinical impairment. It is also currently developing a goggles-based mobile device which generates high definition displays that are manipulated and moved according to the device’s ability to track each eye individually. All these new technologies aim to restore mobility and independence to visually impaired people.

Upon initial closing, I.V.S. executives Ran Yam and Dan Oz will join OphthaliX’s Board of Directors. Ran Yam will be appointed Chief Executive Officer of OphthaliX and Dan Oz Chief Technology Officer.

Dr. Pnina Fishman, Can-Fite and OphthaliX CEO, mentioned in a statement “We are thrilled to take this important step towards acquiring I.V.S and are excited about the potential of this acquisition as we pursue our strategy of re-positioning OphthaliX as a company that addresses substantial ophthalmologic markets through both medical devices and pharmaceutical products. We welcome the I.V.S. team to OphthaliX.”

Ran Yam, I.V.S. CEO, also mentioned in a statement “There are significant synergies between OphthaliX and I.V.S. and we believe that our combined pharmaceutical and medical device development program presents a compelling opportunity. The visions of the OphthaliX team and I.V.S. team are shared and we look forward to working together.”

About Can – Fite

Can-Fite has a number of drugs in various stages of research and development. These drugs are synthetic, highly specific agonists and an allosteric modulator, all targets the A3 adenosine receptor. All drugs are orally bioavailable with an excellent safety profile. Can – Fite stock market evolution http://www.marketwatch.com/investing/stock/canf

About OphthaliX Inc.

OpthaliX

 

OphthaliX Inc. is an advanced clinical-stage biopharmaceutical company that is focused on developing therapeutic treatments for the treatment of ophthalmic disorders. OphthaliX is committed to continuing its development program for its drug candidate CF101, a neuro-protective and anti-inflammatory drug, for the treatment of glaucoma. Patients are currently enrolled for the second segment of the Phase II study and are treated orally with CF101. OphthaliX Inc. stock market evolution http://www.marketwatch.com/investing/stock/opli

About Improved Vision Systems

Improved Vision Systems Ltd. develops medical device technologies to improve sight and diagnose and provide therapies for ocular diseases such as glaucoma, age related macular degeneration (AMD), diabetic retinopathy and oculo-motor pathologies. The company has headquarters in Even Yehuda, Israel.

About Ran Yam

Ran Yam is the CEO of Improved Vision Systems (IVS). He was VP of R&D at Visionix before working for IVS. He was also head of mechanical department and project manager at Negevtech, Product R&D manager at Trellis Photonics and Mechanics Team Leader at ELOP. Mr. Yam received his education from the Technion – Israel Institute of Technology.

About Pnina Fishman, Ph. D.

Professor Fishman is the founder of Can Fite. She was previously a professor of Life Sciences and head of the Laboratory of Clinical and Tumor Immunology at the Felsenstein Medical Research Institute at the Rabin Medical Center. She is an accomplished scientist and an author of more than a hundred publications. She was the CEO of seven years at Mor Research Application. She was also involved in the establishment and served as a member of the Board of Directors of various life sciences technology projects.

PetroVietnam Completes Acquisition of Chevron’s Assets in Vietnam

Vietnam Oil and Gas Group (Petrovietnam) has acquired full interest in Chevron Corp.’s companies in Vietnam. This acquisition provides PetroVietnam the firm operatorship of two production sharing contracts (PSCs) offshore Vietnam and a huge advantage in a gas development project. PetroVietnam has also made itself one of the strongest oil and natural gas group in the region because of this important acquisition deal. This was announced by the country’s national oil company Wednesday.

Petrovietnam

PetroVietnam will take over Chevron Vietnam (Block B) Ltd., the operator of Blocks B and 48/95, this is a 42.38 percent interest in the PSC. The Vietnamese company will also be the new owner of Chevron Vietnam (Block 52) Ltd. that has a 43.4 percent operating stake in Block 52/97. This is located in the same area as Blocks B and 48/95. Chevron has found gas in the two PSCs. These are located in the Malay Basin off the coast of south western Vietnam which was more than a decade ago.

PetroVietnam will hold a 28.7 percent non-operating stake in the Block B Gas Development Project. This will ensure delivery of natural gas from Blocks B & 48/95 and Block 52/97 to existing and proposed power plants located at southern Vietnam. This is after acquiring Chevron Southwest Vietnam Pipeline Co. Ltd.

Vietnam’s NOC mentioned in a press release “Petrovietnam thanks Chevron for its efforts in discovering and proving this large gas resource.” Joint venture partners and the Vietnamese government have approved PetroVietnam’s acquisition. This acquisition took effect June 17.

Nguyen Xuan Son, Chairman of the Members’ Council of Petrovietnam, mentioned in an interview “The Block B gas project is Petrovietnam’s main oil and gas project. The project is of major significance, contributing to ensuring the energy security of the country and promoting the socio-economic development of the region.”

Nguyen Xuan Son also mentioned “Petrovietnam’s completion of the acquisition of Chevron’s assets in Vietnam will facilitate the acceleration of field development and the implementation of the component projects in order to make gas more quickly available to serve the development needs of the national economy.”

About PetroVietnam

PetroVietnam is the trading name of Vietnam Oil and Gas Group (PVN). In Vietnamese: Tập đoàn Dầu khí Quốc gia Việt Nam. PetroVietnam has become a vital resource in the industry since it was established in 1977. The company’s activities, through its various companies and wholly owned subsidiaries, covers all the operations from oil and gas exploration and production to storage, processing, transportation, distribution and services. PetroVietnam is wholly owned by the Vietnamese central government, it is responsible for all oil and gas resources in the country. It has also become its country’s largest oil producer and second-largest power producer.

About Nguyen Xuan Son

Mr. Nguyen Xuan Son is the Chairman, Chief Executive Officer and President of Vietnam Oil and Gas Corporation. He has been a prominent officer and chairman in numerous ventures and companies in the industry and serves as a Member of the Advisory Board at Providential Capital Management Limited. Mr. Son has a Bachelor of Oil Economics degree from the Soviet Union. He is an Economics Engineer and holds a BA in Economics from the Economic Department of Vietnam National University in Hanoi, Vietnam in 1984.

About Chevron Corporation

Chevron

 

Chevron Corporation is an American multinational energy corporation. It is one of the successor companies of Standard Oil. Chevron is headquartered in San Ramon, California, and is active in more than 180 countries. Chevron is involved in all the aspects of the oil, gas, and geothermal energy industries, such as exploration and production; refining, marketing and transport; chemicals manufacturing and sales; and power generation.

As of 2014, Chevron is one of the world’s largest oil companies. Chevron ranked third in the Fortune 500 list of the top US closely held and public corporations and sixteenth on the Fortune Global 500 list of the top 500 corporations worldwide.

Chevron’s manufactures and sells products such as fuels, lubricants, additives and petrochemicals. The company’s most significant areas of operations are the west coast of North America, the U.S. Gulf Coast, Southeast Asia, South Korea, Australia and South Africa. In 2010, Chevron sold an average 3.1 million barrels per day of refined products like gasoline, diesel and jet fuel. Chevron’s alternative energy operations are all about geothermal, solar, wind, biofuel, fuel cells, and hydrogen. In the past few years, the company planned to spend at least $2 billion on research and acquisition of renewable power ventures. The company claims it is the world’s largest producer of geothermal energy. Chevron Corporation stock market evolution: http://www.marketwatch.com/investing/stock/cvx

Health Care REIT and Revera, Inc. Acquires Regal Lifestyle Communities Inc. for CAD$766 Million

Health Care REIT and Revera, Inc. (“Revera”) announced that they have entered into a definitive agreement to purchase Regal Lifestyle Communities Inc. (“Regal”) in a 75/25 joint venture (JV) for CAD$12.00 per share in cash. This is a total enterprise value of approximately CAD$766 million, or US$623 million.

HCN

Regal is a publicly traded Canadian corporation that operates 23 seniors housing communities that has more than 3,600 units. It has 13 communities in Ontario, seven in Quebec, and one each in British Columbia, Saskatchewan and Newfoundland. 83% of the portfolio’s net operating income is from Toronto, Montreal, Ottawa and Vancouver.

Tom DeRosa, HCN’s Chief Executive Officer, mentioned in a statement “Together with our partner, Revera, we continue to deliver compelling housing and care settings for Canada’s growing senior population.” He said. “The acquisition of Regal is a rare opportunity to add a large, high-quality private pay portfolio concentrated in Canada’s largest metropolitan markets, where there is strong underlying demand. HCN’s unparalleled relationship model continues to drive transparent and consistent new investment growth. We will continue pursuing strategic international investment opportunities through our teams on the ground in Toronto and London.”

HCN and Revera go a long way together. The two companies have formed a joint venture in May 2013, when HCN acquired 47 seniors housing communities from Revera for CAD$1.34 billion. Including the acquisition of Regal, the deal is projected to comprise of gross investments of CAD$2.8 billion. More details about the acquisition will be provided in the following weeks to come.

Thomas G. Wellner, President and Chief Executive Officer of Revera, also mentioned in a statement “Revera is entering an exciting period of expansion in the senior living sector focused on growth and innovation across its private pay portfolio in Canada, the United States and the United Kingdom.” He said. “We are pleased to strengthen our relationship with HCN and to grow our leadership position in Canada through the acquisition of these high-quality retirement communities. We look forward to welcoming the Regal teams to Revera and to working together to continue to create a great experience for seniors in our communities.”

About Health Care REIT

Health Care REIT or HCN is one of the partners of families in health care. The company has formed relationships with leading health care systems and seniors for housing operators in the U.S and abroad. Health Care REIT stock market evolution http://www.marketwatch.com/investing/stock/hcn

About Thomas J. DeRosa

Mr. DeRosa is Chief Executive Officer of HCN. Mr. DeRosa has served as Chief Executive Officer since April 2014.  Mr. DeRosa has extensive knowledge of the real estate industry and capital markets from his experience as Vice Chairman and Chief Financial Officer of The Rouse Company and at Deutsche Bank and Alex. Brown & Sons and his leadership of the Company as Chief Executive Officer provides him with intimate knowledge of the Company’s business and operations.

About Revera, Inc.

Revera

 

Revera Inc., is a privately owned Canadian provider of accommodation, care and services for retirees and seniors. It operates long term care and seniors housing retirement residences. Formerly named Retirement Residences Real Estate Investment Trust, it used to be publicly traded on the TSX under the symbol RRR.UN and other various symbols but was taken private in 2007. The company is now the second-largest network of accommodation, care and services for seniors in North America, serving older adults at more than 500 locations in Canada and the United States. It also has holdings in the UK. The company is headquartered in Mississauga, Ontario. There are also corporate offices in Cambridge, Ontario and Meriden, Connecticut (USA)

About Thomas Wellner

Thomas Wellner has extensive global experience in biotech, pharmaceuticals and health care services in public and private businesses. Mr. Wellner joined Revera in 2014. Mr. Wellner holds an Honours Bachelor of Science in Life Sciences from Queen’s University, recently completed his ICD Directors Education Program at the Rotman School of business and has completed executive education through Harvard Business School.

About Regal Lifestyle Communities

Regal

Regal Lifestyle Communities’ goal is to provide the highest-quality retirement care in Canada; it is the innovation and guidance of our Leadership Team that makes this possible. Regal Lifestyle Communities employs great people to provide residents with an exceptional retirement experience. All residences are locally-operated by the best staff . Regal Lifestyle Communities’ approach is simple: they emphasize care, comfort, and peace of mind. They provide customers with peace of mind through consistent, comprehensive, and high-quality care services offered in accommodations designed for safety and comfort. Regal Lifestyle Communities stock market evolution http://www.bloomberg.com/quote/RLC:CN

CVS Health Acquires Target’s Pharmacy and Clinic Business for $1.9 Million

CVS Health Corporation and Target Corporation have announced that they have created a definitive agreement. CVS Health will acquire Target’s pharmacy and clinic businesses for approximately $1.9 billion. CVS Health will also acquire Target’s more than 1,660 pharmacies located in 47 states. These will be operated through a store-within-a-store format and branded as CVS/pharmacy.

CVS

A CVS/pharmacy brand will be included in every new Target store that offers pharmacy services. The new Target clinics will be called MinuteClinic, and CVS Health will also open up to 20 new clinics in Target stores as a part of the transaction. The new clinics will be part of CVS/minute clinic’s plan to operate 1,500 clinics by 2017.

 

Also a part of the transaction, CVS Health and Target plan to develop five to 10 small, stores over a two-year period following the closing of the transaction. These will be branded as TargetExpress and include a CVS/pharmacy.

 

Larry Merlo, CVS Health President and CEO, mentioned in a statement: “This strategic relationship with Target supports the highly complementary customer base, brand and culture we share.” He said. “When we introduced the new name for our company, CVS Health, we began a new era of growth with a broader health care focus and an appreciation of the rise of health care consumerism with consumer choice and accountability growing. This relationship with Target will provide consumers with expanded options and access to our unique health care services that lead to better health outcomes and lower overall health care costs.”

Brian Cornell, Target Chairman and CEO, also mentioned in a statement “At Target, we’ve talked a lot about the evolving preferences of our guests and this partnership demonstrates that we’re committed to putting them at the forefront of everything we do.” He added “By partnering with CVS Health, we will offer our guests industry leading health care services, and at the same time, sharpen our focus on elevating the way we deliver wellness products and experiences to our guests.”

Following completion of the transaction, Target guests will have access to CVS Health’s leading pharmacy care programs and medical clinic services. Pharmacy programs, including Pharmacy Advisor, Specialty Connect and Maintenance Choice, will help consumers achieve better medication adherence through convenience and enhanced pharmacy care counseling. The company is also committed to providing low-cost generic drug option. This acquisition is consistent with each company’s stated goals of investing in core businesses that help drive growth.

The transaction is subject to customary closing conditions, including necessary regulatory clearance. In-store changes will be rolled out over a period of several months thereafter, as CVS Health and Target work to ensure the smoothest possible transition for all pharmacy and clinic patients. CVS Health is committing to offering the approximately 14,000 in-store Target health care professionals comparable positions with CVS Health as part of the transition. Also following the deal closing, Target will further evaluate the business impact and related support needs at its headquarters locations.

About CVS Health

CVS Health (formerly CVS Caremark Corporation) is an American retailer and health care company. CVS Health operates over 7,700 CVS Pharmacy and Longs Drugs stores; a pharmacy benefit manager, mail order and specialty pharmacies, a retail-based health clinic subsidiary, MinuteClinic; and an online pharmacy, CVS.com. CVS Health is chartered in Delaware, and is headquartered in Woonsocket, Rhode Island, where its four business units are also headquartered. CVS Health stock market evolution: http://www.marketwatch.com/investing/stock/cvs

About Larry Merlo

Larry Merlo is President and Chief Executive Officer of CVS Health. Under Merlo’s leadership, the company is transforming health care by delivering breakthrough products and services. Merlo has received numerous professional honors, including his past role as chairman of the Board for the National Association of Chain Drug Stores (NACDS), where he still serves on the Board’s Executive Committee. He is a graduate of the University of Pittsburgh School of Pharmacy.

About Target Corporation

Target

Target Corporation is an American retailing company, founded in 1902 and headquartered in Minneapolis, Minnesota. Target operates 1,934 stores in the United States; it began operations in Canada in March 2013 and operated 127 locations through its Canadian subsidiary. By 2015, it had 133 stores in Canada. Target stock market evolution: http://www.marketwatch.com/investing/stock/tgt

About Brian Cornell

Brian Cornell is chairman of the board and chief executive officer of Target Corporation. He joined Target in 2014 after serving as CEO of PepsiCo Americas Foods, the largest business sector of PepsiCo. Cornell has served on the board of directors for Home Depot and OfficeMax and on the board of trustees for the Culinary Institute of America. He currently serves on the board of directors for the UCLA Anderson Board of Visitors and Polaris Industries Inc. Cornell earned a bachelor’s degree at the University of California Los Angeles in 1981 and attended UCLA’s Anderson School of Management.

Cairn India Will Merge with Vedanta Ltd – Board Approves Merger

Cairn India merges with Vedanta Ltd. The board of directors of the two companies have approved of the merger. Stocks of Vedanta India and Cairn India climbed as much as 3.6 per cent in trade following the announcement of merger. Vedanta India jumped 2.8 per cent to hit an intraday high of Rs 189.20 in the morning trades. Cairn India also surged 3.5 per cent to hit its day’s high of Rs 187.15.

Cairn

Metal and mining company Vedanta Ltd and its subsidiary Cairn India will merge in a deal that will include all shares will give the parent access to Cairn’s $2.7 billion, or about Rs 17,000 crore. This is an amount that will help it reduce debt.

Independent boards of directors of the companies which were owned by billionaire Anil Agarwal, have approved the merger. Minority shareholders of Cairn India will receive one equity share of Vedanta and one redeemable preference share of Rs 10 face value with 7.5% annual dividend, for each share held in Cairn India. Existing Cairn India shareholders will get exposure to metal and mining assets and better shareholder returns.

Ani Agarwal, chairman of Vedanta Plc, mentioned in a statement: “The merger consolidates our position as India’s leading diversified natural resources champion, uniquely positioned to support India’s economic growth.” A diversified portfolio from metal to oil exploration will help Vedanta increase earnings volatility in an economic slowdown, allocate capital to projects with better returns, build a stronger balance sheet and lower overall cost of capital.

Tom Albanese, chief executive at Vedanta Ltd, also mentioned in a statement: “The merger will result in improved financial flexibility to allocate capital to the highest return projects and sustain higher dividends.” He added: “The combined entity is uniquely positioned to help unlock India’s wealth of world class energy and mineral resources.”

Vedanta Ltd, which has already refinanced $400 million is now in the process of refinancing additional $2 billion, or about Rs 12,000 crore, by replacing loans from foreign banks with loans from Indian banks to maintain cost of interest at $7.5% or a shade lower. Experts however expect an improvement due to the merger although there may not be any impact on its earnings per share.

About Vedanta Ltd

Vedanta Resources plc is a global diversified metals and mining company with headquarters in London, United Kingdom. It is the largest mining company in India with operations in Australia and Zambia and oil and gas operations in three countries. Its main products are copper, zinc, aluminum, lead and petroleum. It is managing commercial power stations in India. The company is principally owned by Indian billionaire Anil Agarwal through Volcan Investments. According to the New York Times, Vedanta Resources is “known in some parts of the world for having left financial and environmental problems in their wake.” Vedanta Ltd. Stock market evolution: http://www.bloomberg.com/quote/VED:LN

About Anil Agarwal

Anil Agarwal is the founder and chairman of Vedanta Resources Plc. which he controls through Volcan Investments, a holding vehicle with a 61.7% stake in the business. According to the New York Times, the company is “known in some parts of the world for having left financial and environmental problems in their wake.

About Cairn India

Cairn India is an oil and gas exploration and production company, with headquarters in Gurgaon, India. It is a subsidiary of Vedanta Resources. Cairn India is one of the largest independent oil and gas exploration and production companies in India. Cairn India has a portfolio of nine block located in four strategically focused areas: one in Rajasthan; two on the west coast of India; five on the east coast of India (including one in offshore Sri Lanka) and one in offshore South Africa.

Cairn produces oil and gas from three blocks in India. Top 250 Global Energy Company Rankings by Platts, ranked Cairn India for being the World’s fastest-growing energy company in 2011. Cairn plans to invest $3 billion in the next three years in searching for oil from Rajasthan oilfields. Cairn stock market evolution: http://www.moneycontrol.com/india/stockpricequote/oil-drilling-and-exploration/cairnindia/CI37

About Tom Albanese

Vendata

Mr. Tom Albanese is the CEO of Vedanta Resources Plc and Vedanta Limited (formerly known as Sesa Sterlite Ltd/Sesa Goa Ltd), a subsidiary of Vedanta Resources Plc. Mr. Albanese was formerly the Chief Executive of Rio Tinto, a global diversified mining company, from May 2007 to January 2013.  Mr. Albanese holds a Bachelor’s degree in Mineral Economics and a Master’s in Mining Engineering from the University of Alaska. Mr. Albanese was awarded the ‘Mining Foundation of the Southwest’ 2009 American Mining Hall of Fame Award, for his dedication, knowledge, leadership and inspiration to his peers in the mining industry.

Canada Pension Plan Investment Board Won Bidding for General Electric Co.’s Private – Equity Lending Business

Canada Pension Plan Investment Board won the bidding for General Electric Co.’s private-equity lending business. The pension board agreed to pay $12 billion for the transaction. It has managed to lead its way towards the acquisition and has overtaken private-equity firms such as Apollo Global Management LLC and KKR & Co. Experts believe that this is one of the most aggressive bids compared to other competitors’ offers.

Canada

Chief Executive Mark Wiseman, leader of the fund, has more than 260 billion Canadian dollars (US$211 billion) under management, up from C$219.1 billion a year ago. Canada’s chief actuary estimates that these will reach C$300 billion by 2020.

The Canadian funds are “no longer content just being passive investors in private-equity funds,” said Jonathan Melmed, head of the Canada practice and co-chair of the global private-equity and buyout practice at law firm Morrison & Foerster LLP. The fund’s aggressive approach in acquiring GE Capital’s private-equity lending unit. The business lends money to private-equity firms for the acquisition and operation of middle-sized companies and is responsible for 400 loans. The company employs about 300 people who manage new loans and transactions for customers.

About the Canada Pension Plan Investment Board

The Canada Pension Plan Investment Board operates a debt business, which was established in 2009 to take advantage as banks backed out during the credit crunch. The midsize-lending market, where the GE business is considered a leader, appealed to the Canadian fund due to a much higher recurring returns it offered, said Mark Jenkins, head of the fund’s private investments.

Under the direction of the then Canadian Finance Minister Paul Martin, the CPP Investment Board was created in 1997 as a group that was independent of the government to monitor and invest the funds held by the Canada Pension Plan (CPP). The CPP Investment Board is a crown corporation created by an Act of Parliament. It oversees the operation of various aspects of the CPP reserve fund. It also plans changes in the direction and the board of directors that is accountable to but independent from the federal government. The CPP Investment Board’s mandate is in its founding legislation, the Canada Pension Plan Investment Board Act. Its investing mandate is to achieve a “maximum rate of return, without undue risk of loss.”

About Mark Wiseman

Mark Wiseman is the President and Chief Executive Officer of CCP. Mark assumed the role of President and CEO in July 2012. He is responsible for leading the CPP Investment Board and its investment activities. Mark Wiseman joined the CPP Investment Board in June 2005 as the organization’s Senior Vice-President, Private Investments. He was later named Executive Vice-President, Investments, responsible for managing all of the investment activities of the CPP Investment Board – Public Market Investments, Private Investments and Real Estate Investments. Born in Niagara Falls, Ontario, Mark holds a BA from Queen’s University and a law degree and MBA from the University of Toronto. In 2006, Mark was named to Canada’s Top 40 Under 40.

Jonathan M.A. Melmed

Jonathan M.A. Melmed, Age 35, New York Office, Corporate. Mr. Melmed’s practice focuses on international corporate mergers and acquisitions private equity and venture capital. He is a member of Chadbourne’s Canada practice and private equity group. Mr. Melmed represents corporations as well as private equity, venture capital and hedge funds in domestic and cross-border M&A, private equity and venture capital transactions, including U.S.-Canada and U.S.-Israel. He has also represented numerous companies and investment banks in U.S. securities transactions, including initial public offerings, as well as both public and private debt and equity offerings. While Mr. Melmed has broad sector experience, including in the media and life sciences sectors, his recent practice has focused heavily on renewable energy. Mr. Melmed received a B.A., with Great Distinction and Dean’s Honour List, from McGill University in 1994 and an LL.B. and a B.C.L., with Distinction, from McGill University, Faculty of Law, in 1998. He is a member of the New York and Quebec, Canada bars.

About General Electric

GE new

General Electric (GE) is an American multinational conglomerate corporation incorporated in New York. General Electric has headquarters in Fairfield, Connecticut. As of 2015, the company operates through the following segments: Power and Water. Oil and Gas, Energy Management, Aviation, Healthcare, Transportation, and Capital. In 2011, General Electric has ranked among the Fortune 500 companies as the 26th-largest firm in the U.S. by gross revenue. As of 2012 the company was listed the fourth-largest in the world among the Forbes Global 2000, further metrics being taken into account. General Electric stock market evolution http://www.marketwatch.com/investing/stock/ge

Lavazza Agrees to Purchase Danish Coffee Brand from D. E. Master Blenders

Italy’s Lavazza coffee brand has reached agreement to purchase a Danish coffee brand from D.E. Master Blenders. Dutch group D. E. Master Blenders is seeking to comply with European competition authorities’ conditions for approving its merger with Mondelez’s coffee business. One of the conditions for the merger to be cleared was that Mondelez must also sell French brand Carte Noire. Lavazza in April mentioned that it was in contention to purchase Carte Noire. Lavazza however declined to say whether that was still the case after the acquisition o the Danish coffee brand.

Lavaza

The Italian coffee group said on Friday in a statement sent to Reuters. “Lavazza has agreed in terms with D.E. Master Blenders 1753 BV to meet the conditions of the European Commission regarding divestment of the Merrill brand.” Closing of the deal is subject to the Commission’s approval, it also mentioned.

Lavazza did not disclose the financial terms of the deal. Last month, the EC approved the merger of Mondelez’s coffee business with D.E. Master Blenders (DEMB) to create the world’s biggest standalone coffee company, Jacobs Douse Egberts, on condition they sell certain businesses first. ($1 = 0.8914 euros)

About Lavazza

Luigi Lavazza S.p.A. is an Italian manufacturer of coffee products. Lavazza was founded in Turin in 1895 by Luigi Lavazza. The popular coffee brand was initially run from a small grocery store at Via San Tommaso 10. Now the company is being run by the third and fourth generation of the Lavazza family.

Lavazza imports coffee from around the world. Countries in  South America, Central America, Africa, Asia and in North America. Branded as “Italy’s Favourite Coffee,” the company claims that 16 million out of the 20 million coffee purchasing families in Italy choose their brand. Among its offerings today are products such as Top Class, Super Crema, Crema e Gusto, Grand’Espresso, Dek (decaffeinated), and coffee capsules A Modo Mio, “Espresso Point” and BLUE. Lavazza is official coffee at the Italy Pavilion, Expo 2015.

About DE Master Blenders

Douse Egberts is the main brand name for D.E. Master Blenders 1753, a multinational tea and coffee company from the Netherlands. It was founded in Joure in the Netherlands by Egbert Douwes in 1753 as By 1925 it had changed its name to Douse Egberts (which is meaning Douse, the son of Egbert), and had introduced the red seal as its logo. The company expanded through Europe, acquiring other tea, coffee and tobacco companies, such as the UK tea distributor Hornimans, until it was taken over by the Sara Lee Corporation in 1978. The tobacco interests, Van Nelle and Drum rolling tobacco, were sold to Imperial Tobacco in 1998.

In 2001 the company in collaboration with Philips produced the Senseo coffee maker system. With profits from the coffee division are considers from rivals such as Nestlé and Kraft, and being unable to find a buyer, in 2012 Sara Lee split off the coffee division into D.E Master Blenders 1753, offering share-holders one share in the new company for each main share they held. In 2013 German investor group Joh. A. Benckiser made an offer to purchase D.E Master Blenders 1753 for $9.8 billion. D. E. Masters stock market evolution http://www.marketwatch.com/investing/stock/dembf

About Mondalez

Mondelez

Mondelēz International, Inc. is a North American multinational confectionery, food and beverage company. Currently it has around 107,000 people around the world. It comprises the global snack and food brands of the former Kraft Foods Inc. The Mondelēz name, adopted in 2012, came from the input of Kraft Foods employees at the time, a combination of the words for “world” and “delicious” in Romance languages.

Mondelēz International manages snack brands around the globe, including cookies and crackers (Oreo, Chips Ahoy!, TUC, Evita, Triscuit, Club Social, Barni, Peek Freans) and gum and candy such as popular Cadbury Dairy Milk and Dentyne. The company is headquartered in Deerfield, Illinois, a Chicago suburb, and is a manufacturer of chocolate, biscuits, gum, confectionery, coffee, and powdered beverages. The company consists of the global snacking and food brands from Kraft Foods Inc. following the spin-off of its North American grocery operations in October 2012. Mondelēz International’s portfolio includes several billion-dollar brands such as Cadbury (acquired through a buy out of Cadbury in 2010) and Milka chocolate, Jacobs coffee, Toblerone, Nabisco and Oreo cookies, powdered beverages, and Trident gums. Mondelēz International has annual revenue of approximately $36 billion and operations in more than 80 countries. Mondelēz Canada controls the rights to Christie Brown and Company, which consists of brands such as Mr. Christie and Dad’s Cookies. The headquarters in Mississauga, Ontario with operations in Scarborough and Montreal. Mondelez stock market evolution http://www.marketwatch.com/investing/stock/mdlz